Showing results (251-260 of 267) with videos related to
Sort By:
Pageof 27
Neurology|May 7, 2008
CSF biomarkers in frontotemporal lobar degeneration with known pathologyH Bian, J C Van Swieten, S Leight, et al.Cancer Treatment Reports|April 1, 1982
Results of treating Hodgkin's disease without a policy of laparotomy stagingD E Bergsagel, R E Alison, H A Bean, et al.Neurology|August 10, 2005
Rate of progression differs in frontotemporal dementia and Alzheimer diseaseK Rascovsky, D P Salmon, A M Lipton, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1996
Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matterC DeCarli, C L Grady, C M Clark, et al.Neurology|October 5, 2007
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutationsA S Chen-Plotkin, W Yuan, C Anderson, et al.Archives of Neurology|July 25, 1998
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotypeD Galasko, L Chang, R Motter, et al.Neurology|November 5, 2010
Novel CSF biomarkers for frontotemporal lobar degenerationsW T Hu, A Chen-Plotkin, M Grossman, et al.Cancer Treatment Reports|November 1, 1981
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinomaW K Evans, R Feld, G DeBoer, et al.Neurology|April 18, 2007
Cognitive and motor assessment in autopsy-proven corticobasal degenerationR Murray, M Neumann, M S Forman, et al.Canadian Medical Association Journal|May 19, 1979
Ovarian irradiation and prednisone therapy following surgery and radiotherapy for carcinoma of the breastJ W Meakin, W E Allt, F A Beale, et al.Pageof 27